PatientTrader1
Posted - 4 days ago
$SKYE from Glaucoma experts to weight loss specialists…. Please RUN AWAY!!!.. its a SCAM from wherever you look at it…….
NoRiskNoGainEver
Posted - 4 days ago
$SKYE here you go guys!
Food for thought 😏
MissionaryTrader
Posted - 5 days ago
$SKYE as disappointing as the recent price action and volume has been with SKYE, it could be worse. I keep hearing people on this board talking up ALT. 32% of their float is shorted. Meanwhile, SKYE‘s float is only shorted around 8%. I still believe this stock will rocket higher on positive data.
YazzJr
Posted - 5 days ago
$SKYE A low volume bleed to death.
slayer70
Posted - 5 days ago
$SKYE If this hits a 1$, I think I'll jump back in and play it Once again as a trade.
aricray
Posted - 6 days ago
$SKYE Anything under $5.15 is better than the last executive purchases.
YazzJr
Posted - 6 days ago
$SKYE This stock drops no problems on very low volume. Not a good sign for the short term. Might revisit the $3's.
Havana20
Posted - 1 week ago
$SKYE I started buying again!!!
Picklerinthekitchen
Posted - 1 week ago
$SKYE ouch ! Being patient for under $2
Polsky
Posted - 1 week ago
$SKYE buying back in at $1.5
YazzJr
Posted - 1 week ago
$SKYE WTF man???
Ronald_Lamb
Posted - 1 week ago
$SKYE $ACHV MYNZ Wow, this is insane news! Don't miss out. The train is leaving the station. Add it to your watchlist to see what happens next. 😏
Multipliers
Posted - 1 week ago
$SKYE
https://finance.yahoo.com/news/skye-bioscience-surpasses-50-patient-120000058.html
YazzJr
Posted - 1 week ago
$SKYE It wants to push above $6...just needs to gather the strength to do it.
Rascal7777
Posted - 1 week ago
$SKYE meanwhile at ALT
Picklerinthekitchen
Posted - 1 week ago
$SKYE $ALT is the best weight loss Nash winner in the short term.
TKrsponsibility
Posted - 1 week ago
$SKYE buy DOGE NOW
JosRyan
Posted - 1 week ago
MYNZ 🔥 Perfect time to jump in, cheapest dip!!! Shorts volume increased. Low Float only 29M outstanding shares. Any buy-in will make this fly to the moon. Here is why… 1.Frankie Muniz backing Mainz (yes, the Malcolm guy & NASCAR #33 now repping MYNZ). 2.Petra, ex-Obama advisor, hinted at a big U.S. lab partner. Solid source! 3.Six news hits in 3 weeks—momentum. 4.Already solid in the EU, not new but expanding, with insurance covering their tests. 5.Their test has 88% accuracy vs. EXAS (42%) & GH (20%)—big edge! 6.$1.5M private placement in the bag. 7.CEO teased big plans ahead. 8.Offering Deal $SKYE $ADVM
YazzJr
Posted - 2 weeks ago
$SKYE Nice finish. A little pull back at the end there but tempered down the RSI a bit. So maybe some breathing room to continue up next week.
YazzJr
Posted - 2 weeks ago
$SKYE SKYE bucking the trend and maybe finishing strong into the end of the day. If this can get above $6 next stop should be $8ish.
YazzJr
Posted - 2 weeks ago
$SKYE The movement on this stock is hilarious. Goes way up, redlines on the RSI and fall back down usually staying up a few cents every day...It's going to be a long climb up...but it's fine..
YazzJr
Posted - 2 weeks ago
$SKYE Nice ER and Conference Call. Plenty of cash on hand for them to run for the next two and a half years. No worries about dilution any time soon. The Trials are on schedule with data coming out in the second qtr '25(I am hearing April sometime for that data readout.) This should start moving back up to where it was back in May and June. But the big take away was their hefty cash position to last them for the next 8 qtrs or so.
Multipliers
Posted - 2 weeks ago
$SKYE The future looks 🌞 bright.
"The United States Court of Appeals for the Ninth District vacated the judgment with respect to an outstanding litigation matter. As a result, the Company will be able to recover the $9 million restriction on its cash related to the appeal bond, which is expected to be released before year-end."
"Cash and cash equivalents totaled $76.5 million, including restricted cash of $9.1 million on September 30, 2024. The Company expects its current capital to fund projected operations through Q3 2027."
MissionaryTrader
Posted - 2 weeks ago
$SKYE a lot of good information from the conference call today regarding the clinical trials and the long term outlook for nimacimab. The institutional Investors that were present on the call and who also participated in the question and answer period lended to the credibility of SKYE as a solid investment as well. Also, it sounds like the appeals court vacated the cummings lawsuit against Skye which will free up around $9m that was tied up with the bond. Highly recommend listing to the call archived on Skye’s website.
RM_111
Posted - 2 weeks ago
$SKYE
RM_111
Posted - 2 weeks ago
$SKYE
Multipliers
Posted - 2 weeks ago
$SKYE Shares New Data Via ObesityWeek 2024 Satellite Presentation This week, following its news release on Monday, Skye Bioscience hosted a subsequent satellite event in conjunction with the ObesityWeek 2024 Conference in San Antonio. At this event Skye provided more detail regarding important new pre-clinical data relating to peripheral vs. central CB1 inhibition and the unique potential role of nimacimab as a truly peripherally-restricted CB1 inhibitor. We highlighted data showing that peripheral CB1 inhibition alone is enough to drive significant weight loss. Targeting central CB1 receptors does not significantly impact weight loss and can cause unwanted neuropsychiatric adverse events. Discover how nimacimab stands out by achieving effective peripheral CB1 inhibition without central exposure, leading to powerful benefits: dose-dependent weight loss, fat mass reduction with lean mass preservation, and improved glycemic control. Watch the full presentation here: https://youtu.be/hqa4y9e3APc
YazzJr
Posted - 2 weeks ago
$SKYE Wow, do people really use stops with this stock. The MM's went and grabbed your shares. So dumb.
slayer70
Posted - 2 weeks ago
$SKYE Viking just came out with a pill that has promising results